United States Healthcare Providers & Services

Flora Growth Corp (FLGC)

Track

Track

Flora Growth Corp has seen recent insider activity characterized by a significant purchase. On July 20, 2026, Executive Chairman Heinrich Michael acquired shares valued at approximately $3.48 million. This transaction represents the sole insider activity recorded over the past 90 days, following the company's most recent earnings report which showed a notable earnings per share miss.
Ticker: FLGC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Flora Growth Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Heinrich Michael Executive Chairman Executive Director
Transaction date
Purchase
Price
197.92
Quantity 76,312 -5.3%
Value US$4,994,092
Heinrich, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
252.51
Quantity 27,241
Value US$4,873,314
2.7
Starke, Clifford Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
109.47
Quantity 88,119 -5.6%
Value CA$4,608,695
3.1
Starke Clifford CEO Executive Director
Transaction date
Purchase
Price
0.95
Quantity 6,795 +13323.5%
Value US$6,455
3.7
Wolkin, Harold Morton Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.97
Quantity 5,000 +25.0%
Value US$4,850
3.2
Wolkin Harold Non-Executive Director
Transaction date
Purchase
Price
0.98
Quantity 15,000 +150.0%
Value US$14,685
3.2
Wolkin Harold Non-Executive Director
Transaction date
Purchase
Price
0.95
Quantity 5,000 +100.0%
Value US$4,760
3.2
Wolkin Harold Non-Executive Director
Transaction date
Purchase
Price
0.96
Quantity 5,000 +inf%
Value US$4,810
3.1
Starke Clifford CEO Executive Director
Transaction date
Purchase
Price
0.95
Quantity 51 +0.0%
Value US$48
3.1
Starke Clifford CEO Executive Director
Transaction date
Purchase
Price
1.90
Quantity 526,315 +1335.9%
Value US$999,998
MERCHAN LUIS Affiliate
Transaction date
Proposed sale
Price
0.26
Quantity 500,000
Value US$130,000
ROA JUAN CARLOS GOMEZ Director Non-Executive Director
Transaction date
Proposed sale
Price
0.42
Quantity 500,000
Value US$208,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-20 2026-07-20 B Purchase
Heinrich Michael

Executive Chairman

Executive Director
76,312 -5.3%
197.92
US$4,994,092 		76,312 -5.3% 197.92 US$4,994,092
2025-10-27 2025-10-23 B Purchase
Heinrich, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
27,241
252.51
US$4,873,314 		27,241 252.51 US$4,873,314
2024-09-18 2024-09-13 B Purchase
2.7
Starke, Clifford

Director of Issuer, Senior Officer of Issuer

Executive Director
88,119 -5.6%
109.47
CA$4,608,695 		88,119 -5.6% 109.47 CA$4,608,695
2024-09-17 2024-09-13 B Purchase
3.1
Starke Clifford

CEO

Executive Director
6,795 +13323.5%
0.95
US$6,455 		6,795 +13323.5% 0.95 US$6,455
2024-09-11 2024-09-06 B Purchase
3.7
Wolkin, Harold Morton

Director of Issuer

Non-Executive Director
5,000 +25.0%
0.97
US$4,850 		5,000 +25.0% 0.97 US$4,850
2024-09-11 2024-09-06 B Purchase
3.2
Wolkin Harold
Non-Executive Director
15,000 +150.0%
0.98
US$14,685 		15,000 +150.0% 0.98 US$14,685
2024-09-11 2024-09-06 B Purchase
3.2
Wolkin Harold
Non-Executive Director
5,000 +100.0%
0.95
US$4,760 		5,000 +100.0% 0.95 US$4,760
2024-09-11 2024-09-06 B Purchase
3.2
Wolkin Harold
Non-Executive Director
5,000 +inf%
0.96
US$4,810 		5,000 +inf% 0.96 US$4,810
2024-09-06 2024-09-05 B Purchase
3.1
Starke Clifford

CEO

Executive Director
51 +0.0%
0.95
US$48 		51 +0.0% 0.95 US$48
2024-04-09 2024-04-08 B Purchase
3.1
Starke Clifford

CEO

Executive Director
526,315 +1335.9%
1.90
US$999,998 		526,315 +1335.9% 1.90 US$999,998
2023-05-22 2023-05-22 PrS Proposed sale
MERCHAN LUIS

Affiliate
500,000
0.26
US$130,000 		500,000 0.26 US$130,000
2022-12-01 2022-12-01 PrS Proposed sale
ROA JUAN CARLOS GOMEZ

Director

Non-Executive Director
500,000
0.42
US$208,500 		500,000 0.42 US$208,500
Explore more

More insider trading research around Flora Growth Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America